瑞士诺华的地拉罗司治疗什么病

It is an iron chelator indicated for the treatment of chronic iron overload caused by transfusion in patients 2 years of age and older. This indication was approved under accelerated approval based on reductions in hepatic iron concentrations and serum ferritin levels. Continued approval for this indication may be contingent upon verification and characterization of clinical benefit in confirmatory trials.

Deferasirox is indicated for the treatment of chronic iron overload in patients 10 years of age and older with non-transfusion-dependent thalassemia (NTDT) syndrome and a liver iron (Fe) concentration (LIC) of at least 5 mg Fe per gram dry weight (Fe/g dw) and serum ferritin greater than 300 mcg/L. This indication was approved under accelerated approval based on reductions in hepatic iron concentration (less than 5 mg Fe/g dw) and serum ferritin levels. Continued approval for this indication may be contingent upon verification and characterization of clinical benefit in confirmatory trials.

Currently, the one most favored by patients is the one produced by Novartis in Switzerland. Novartis is a pharmaceutical and biotechnology multinational company headquartered in Basel, Switzerland. Its core businesses are in various patent medicines, consumer healthcare, generic medicines, eye care and animal health. According to Medical Companion Travel, the specification of Deferasirox from Novartis Switzerland is 400mg*30 tablets, but the price is only 420$, which is more suitable for patients for long-term use. Since the exchange rate is not static, the price will also fluctuate. For details, please consult Medical Companion Travel.

Recommended related hot articles: /newsDetail/94098.html

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.